Productive Aging Science for The Future You
Shinkowa Pharmaceutical Co., Ltd. has changed its name to
MIRAILAB BIOSCIENCE Inc on January 1st.
Productive Aging Science for
The Future You
MIRAILAB BIOSCIENCE Inc. supplies NMN products with the world's highest quality NMN, carrying out thorough quality control, helping you stay healthy by providing the safest NMN.
MIRAILAB BIOSCIENCE leads the industry in NMN purity, strictly maintaining greater than 99% purity in all products.
Leading the World in Clinical Trials
MIRAILAB NMN was first in the world to be tested in human trials, verifying safety , as well as the expression of sirtuin genes and the increase of melatonin and other growth hormones, at a Japanese national university school of medicine.
Development and intensification of NMN research on companion animals. Started joint research with Yamaguchi University Faculty of Veterinary Medicine (Prof. Toru Kimura: Biofunctional Science and Laboratory Animal Science).
Launched research on NMN and immunity, prevention, and treatment of infectious diseases such as COVID-19.
Conducted joint research with the Graduate School of Integrated Sciences for Life, at the National University of Hiroshima (Prof. Masayuki Shimada), on "elucidation of the effects of NMN on sperm function and fertility."
Concluded a material donation agreement with Washington University in St. Louis (Missouri, USA).
Obtained joint patent application rights with Prof. Daiki Setoyama and Prof. Kang Dongchon of the National University of Kyushu for "Discovery of β-NMN's enhancement effect on coenzyme Q in vivo."
Study on “Longevity and Anti-Aging Effects of NMN Administration in Dogs: Confirmation of the Effects of Activation of Longevity Genes on Blood Composition and Intestinal Microbiota," conducted in collaboration with the Faculty of Veterinary Medicine, Yamaguchi University (Prof. Toru Kimura: Biofunctional Science and Laboratory Animal Science).
Collaboration launched with The Systems Biology Institute aimed at elucidating the biomolecular mechanisms of NMN.
The world's first clinical study on the effects and mechanism of action of NMN in humans through oral ingestion (24 weeks), conducted at the Graduate School of Biomedical and Health Sciences, National University of Hiroshima.
■Washington University School of Medicine in St. Louis
■Yamaguchi University School of Medicine Graduate School
■Yamaguchi University, Joint Faculty of Veterinary Medicine
MIRAILAB BIOSCIENCE Inc. Life Science Laboratory
1-14-4, 2F, Prairie Ginza Bldg ., Tokyo, 104-0061, Japan (Ginza Life Science Building)
Staffed by one Doctor of Medicine and one Doctor of Engineering
SOCIAL, RESEARCH, and EDUCATION CONTRIBUTIONS
Arts and culture
・ Enriching musical life as a supporting member of the Tokyo Philharmonic Orchestra
・ Sponsor of classical music radio OTTAVA "Wellness tonight!” (Thursdays at 22:00, Sundays at 21:00)
・Washington University in St. Louis, Missouri, USA. Donation of NMN to the Center for Genome Sciences and Systems Biology, Dr Jeffrey Gordon, Director.
・Washington University in St. Louis, Missouri, USA. Donation of of NMN to the Department of Developmental Biology and Department of Medicine, laboratory led by Professor Shin-Ichiro Imai.
・ Sponsorship of the First International Symposium on Aging Research and the related Public Lectures commemorating the establishment of the Institute for Research on Productive Aging (IRPA).
・Contribution to the Gordon Research Conferences
NOW MAKE NEXT
The MIRAILAB BIOSCIENCE mission is to improve the well-being of our customers and society through rigorous development of productive aging science.
In about 40 years, the world population will exceed 10 billion, while the elderly in developed regions will reach 27.6% of the population amid declining birth rates.
The arrival of a “super-aging” society is becoming an issue not only in Japan but worldwide.
And Japan, with its aging population already exceeding 28%, is now faced with a new challenge: how to extend healthy life expectancy while absolute life expectancy is increasing due to advances in medical technology.
In light of this, MIRAILAB BIOSCIENCE is developing NMN-based nutraceuticals, inspired by the potential discovered in the early research of pioneering scientists and motivated by positive results in clinical trials and the feedback of our customers.
How far can science expand the possibilities of humankind?
How well can we reflect the benefits of science in our lives?
MIRAILAB BIOSCIENCE Inc. aspires to a new level of Quality Of Life.